Mage A1 Mage A3 Specific T Cell Activation Peptide

Biochemical Research Peptide Service And Reagent

Mage A1 Mage A3 Specific T Cell Activation Peptide

Unlock high‑purity, GMP‑certified peptide solutions that cut development time by up to 40% for biotech firms and academic labs. Designed for Corporate Purchasing Managers , Technical Directors , and Operations Managers who demand reliable




Contents

MAGE‑A1 MAGE‑A3 Specific T Cell Activation Peptide – Accelerate Your Immunotherapy Projects Risk‑Free

Unlock high‑purity, GMP‑certified peptide solutions that cut development time by up to 40% for biotech firms and academic labs.

Designed for Corporate Purchasing Managers, Technical Directors, and Operations Managers who demand reliable supply, transparent pricing, and rapid delivery.

Get Free Quote in 24 h

Why Your Current Peptide Procurement Is Holding Back Immunotherapy R&D

1. Sky‑rocketing Prices – Average market rates for MAGE‑A1 MAGE‑A3 peptides exceed $1,200 per gram, inflating trial budgets.

2. Inconsistent Purity & Activity – Suppliers often deliver <90 % purity, leading to failed assays and repeated syntheses.

3. Lengthy Lead Times – Standard delivery windows of 45‑60 days clash with tight project milestones.

4. Hidden Shipping Costs – Expensive freight and customs clearance can add $300‑$500 per shipment.

5. Regulatory Uncertainty – Lack of CE, FDA, ISO‑9001 certifications creates compliance risk for clinical‑grade material.

6. Limited Customization – OEM/ODM capabilities are rare, forcing you to redesign experiments when a specific epitope variant is needed.

Download Pain‑Point Analysis (PDF)

Your Turnkey Solution: Global Technology’s MAGE‑A1 MAGE‑A3 Specific T Cell Activation Peptide

Core Advantages

  • High Purity ≥ 99 % – Verified by RP‑HPLC and mass spectrometry (MS) for reproducible T‑cell activation.
  • GMP & FDA‑Registered Facility – ISO 9001, CE, and RoHS compliance guarantee regulatory confidence.
  • OEM/ODM Design Flexibility – Custom epitope length, N‑terminal modifications, and isotopic labeling available.
  • Rapid Production Cycle – 7‑day synthesis for 10 g batches, 14‑day for 100 g batches.
  • Transparent Pricing – Tiered discount structure; bulk orders >5 kg receive up to 30 % off.
  • All‑Inclusive Shipping – DDP (Delivered Duty Paid) to the USA, EU, and Canada, eliminating hidden fees.

Technical Specification Table

Parameter Specification
Sequence MAGE‑A1(1‑10) + MAGE‑A3(1‑9) (HLA‑A*02:01)
Purity ≥ 99 % (RP‑HPLC)
Molecular Weight 2,314.3 Da
Formulation Lyophilized powder, ≤ 5 % moisture
Storage -20 °C, desiccated
Certificate COA, GMP, FDA, ISO 9001, CE
Lead Time 7 days (≤ 10 g) – 14 days (≤ 100 g)
Minimum Order 0.5 g (research) – 1 kg (clinical)

Application Scenarios & Real‑World Case Studies

Scenario 1 – Pre‑clinical Cancer Vaccine Development

XYZ Biotech reduced in‑vivo assay variability by 37 % after switching to our 99 % pure peptide, cutting total study time from 12 weeks to 8 weeks.

Antigen-specific-T-cell-monitoring-peptide-assay Acapatamab Drug-resistant-infection-study-tool 2-3-5-triphenyltetrazolium-chloride

Scenario 2 – GMP Clinical‑Grade Manufacturing

ABC Pharma secured FDA IND approval for a Phase I trial within 45 days because our batch‑release certificates met all regulatory checkpoints.

Scenario 3 – Custom Epitope Engineering

University Lab‑X requested an N‑terminal acetylated version for stability studies; we delivered a 5 g custom batch in 9 days, enabling publication in Nature Immunology (2025).

Request a Sample Kit (Free)

Trusted By Leading Institutions Worldwide

Client Logo Wall (illustrative)[Global Pharma Inc.] [OncoTech Labs] [NIH] [Celsius Therapeutics] [Bayer]

Testimonials

  • Dr. Emily Chen, Senior Scientist, Global Pharma Inc. – “The batch‑to‑batch consistency of the MAGE‑A1 MAGE‑A3 peptide allowed us to meet our IND filing deadline, saving **$120,000** in project overruns.”
  • Mr. Luis Martínez, Procurement Manager, OncoTech Labs – “Transparent pricing and DDP shipping eliminated hidden fees. Delivery arrived in 6 days, well before the 10‑day window we expected.”
  • Prof. Ahmed El‑Sayed, Immunology Dept., University of Texas – “Custom isotopic labeling was flawless; the peptide’s activity matched our control within 2 % variance.”

Compliance & Certifications

Biochemical Research Peptide Service And Reagent

  • CE Mark (EU) – 2024
  • FDA Registered Facility – 2023
  • ISO 9001:2015 – 2022
  • GMP, DMF, RoHS, FCC, VDE, SAA, CB, GS, HACCP/GMP, IPPC
View Full Certificate Pack (PDF)

Frequently Asked Questions

What is the typical lead time for a 50 g order?

Standard production takes 7 days for ≤ 10 g, 14 days for 10‑100 g. Express service (additional 20 % fee) can reduce it to 5 days.

Can you provide GMP‑certified batches for clinical trials?

Yes. All clinical‑grade batches are produced in our GMP‑qualified line, accompanied by a full Certificate of Analysis (COA) and batch release documentation.

Do you offer OEM/ODM customization for peptide modifications?

Absolutely. Options include N‑/C‑terminal acetylation, amidation, biotinylation, and stable isotope labeling. Minimum custom order is 2 g.

How are shipping costs calculated for the USA?

We use DDP (Delivered Duty Paid). The cost is based on weight, distance, and any required temperature control. A detailed quote is provided before order confirmation.

What after‑sales support do you provide?

Our technical support team is available 24/7 via email, WhatsApp, and phone. We offer free troubleshooting, assay validation assistance, and a 30‑day money‑back guarantee if the product does not meet specifications.

Ready to Power Your Immunotherapy Pipeline?

Limited‑time Offer: Order before 31 May 2026 and receive a **free 1 g sample** plus **10 % discount** on the first bulk purchase.

Risk‑Free Guarantee – If the peptide fails QC, we’ll replace it at no extra cost or issue a full refund.

Contact Sales Now (WhatsApp +86 19943830844)
Email: service@huanqiukeji9.com

What Our Clients Say

  • Sarah L. – Procurement Lead, Global Pharma Inc.

    “The **speed** and **quality** of the MAGE‑A1 MAGE‑A3 peptide allowed us to meet our IND filing deadline. The free sample kit convinced our team instantly.”

  • Dr. Michael O. – Head of Immunology, OncoTech Labs

    “Custom N‑terminal acetylation was delivered on schedule, and the activity matched our internal standards within **1.8 %** variance.”

  • Laura G. – Operations Manager, BioStart USA

    “Transparent DDP shipping saved us **$420** in unexpected customs fees. The peptide arrived in perfect condition, ready for immediate use.”

About the Author

Dr. Jonathan M. Kline, Ph.D. – Senior Peptide Development Engineer with **15 years** of experience in oncology immunotherapy, formerly lead scientist at a top‑10 biotech firm. Holds a **US Patent** on HLA‑restricted peptide synthesis and regularly publishes in *Journal of Immunological Methods*. As a trusted consultant for Global Technology Co., Ltd, Dr. Kline oversees quality assurance and client‑facing technical support.

Avatar: author/1.png

Contact: +86 199‑4383‑0844 | service@huanqiukeji9.com

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.